🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Christopher P. Vellano

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0002-6643-0818

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials”.

Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials

Nature Medicine(2023)10.1038/s41591-022-02103-8

N/A

4.3DataRank · unranked

388 citations

Naval Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka, Funda Meric‐Bernstam +44 more

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

Nature(2022)10.1038/s41586-022-04833-8

N/A

0.731DataRank · unranked

130 citations

Michael G. White, Miles C. Andrews, Manoj Chelvanambi, Russell G. Witt, Joseph R. Daniele +60 more

Patient-derived iPSCs link elevated mitochondrial respiratory complex I function to osteosarcoma in Rothmund-Thomson syndrome

PLoS Genetics(2021)10.1371/journal.pgen.1009971

N/A

0.526DataRank · unranked

17 citations

An Xu, Dandan Zhu, Mo-Fan Huang, Linchao Lu, Mo Liu +24 more

Targeting Oxidative Phosphorylation with a Mitochondrial Complex I Inhibitor is limited by Mechanism-based Toxicity

Research Square(2022)10.21203/rs.3.rs-1506700/v1

N/A

0.269DataRank · unranked

5 citations

Timothy A. Yap, Naval Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka +43 more

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9523

N/A

0.259DataRank · unranked

4 citations

Christopher P. Vellano, Miles C. Andrews, Russell G. Witt, Manoj Chelvanambi, Jennifer L. McQuade +15 more

Subtype and Site Specific–Induced Metabolic Vulnerabilities in Prostate Cancer

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-22-0250

N/A

0DataRank · unranked

17 citations

Daniele Robesti, Sumankalai Ramachandran, Eva Corey, Mark Titus, Yuqi Kang +10 more

Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-1763

N/A

0DataRank · unranked

13 citations

Virginia Giuliani, Wei‐Lien Wang, Daniel J. McGrail, Christopher A. Bristow, Natalie Y.L. Ngoi +46 more

Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000289

N/A

0DataRank · unranked

97 citations

Hampartsoum B. Barsoumian, Grant M. Fischer, Liangpeng Yang, Vivek Verma, Ahmed Younes +9 more

An allele-agnostic mutant-KRAS inhibitor suppresses tumor maintenance signals and reprograms tumor immunity in pancreatic cancer

Science Translational Medicine(2025)10.1126/scitranslmed.adt5511

N/A

0DataRank · unranked

10 citations

Francesca Paradiso, Clint A. Stalnecker, Benson Chellakkan Selvanesan, Fredrik I. Thege, David H. Peng +40 more

LncRNA PVT1 Is a Poor Prognosticator and Can Be Targeted by PVT1 Antisense Oligos in Gastric Adenocarcinoma

Cancers(2020)10.3390/cancers12102995

N/A

0DataRank · unranked

25 citations

Shumei Song, Melissa Pool Pizzi, Guangchun Han, Ailing W. Scott, Jiankang Jin +11 more

Pharmacologic profiling of patient-derived xenograft models of primary treatment-naïve triple-negative breast cancer

Scientific Reports(2020)10.1038/s41598-020-74882-4

N/A

0DataRank · unranked

22 citations

Abena B. Redwood, Xuan Liu, Lei Guo, Shirong Cai, Xinhui Zhou +19 more

Androgen receptor activity promotes resistance to BRAF-targeted melanoma therapy

Research Square(2020)10.21203/rs.3.rs-58480/v1

N/A

0DataRank · unranked

0 citations

Christopher P. Vellano, Michael White, Miles C. Andrews, Joseph R. Daniele, Mark Titus +41 more

PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma

Nature Communications(2021)10.1038/s41467-021-24798-y

N/A

0DataRank · unranked

78 citations

Meredith A. Miller, Chiu-Yi Liu, Stella R. Hartono, Caleb A. Class, Christopher A. Bristow +33 more